The role of the tuft cell inflammasome in infection

簇细胞炎症小体在感染中的作用

基本信息

  • 批准号:
    10418402
  • 负责人:
  • 金额:
    $ 39.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-20 至 2026-12-31
  • 项目状态:
    未结题

项目摘要

Project summary The intestinal epithelium is exposed to different classes of pathogens and is not only instrumental as a first line of defense against invasion of the host, but also signals to immune cells in the underlying lamina propria when pathogens are detected. The NAIP/NLRC4 inflammasome has emerged as an important innate immune sensor in intestinal epithelial cells (IECs) in bacterial gastrointestinal infection, leading to rapid extrusion of infected cells and release of cytokines and eicosanoids upon pathogen recognition. The role of innate immune sensing and the NAIP/NLRC4 inflammasome at the level of individual subtypes of IEC is not well understood. Recently, we discovered that tuft cells uniquely among IECs release the eicosanoid prostaglandin D2 (PGD2) after inflammasome activation. Tuft cells are a rare subtype of IECs primarily known for their role in anti- parasitic immunity. The role of tuft cells during bacterial infection in general as well as the role of released PGD2 in intestinal immunity is unclear. Our preliminary data show that tuft cell inflammasome activation leads to increased tissue levels of IL-22, an antibacterial cytokine that can be produced by TH17 cells or innate lymphoid cells (ILCs), and that tuft cell inflammasome expression protects from small intestinal bacterial colonization. Based on our preliminary data and published data on PGD2 receptor expression we propose a tuft cell- ILC3 communication axis via PGD2. We hypothesize that tuft cells are central sentinels of infection status of the small intestine and capable of shifting the polarization of the intestinal immune response. We aim to define the pathway leading to IL-22 increase after tuft cell inflammasome activation using in vivo models of tuft cell specific inflammasome activation and conditional epithelial PGD2 synthase and ILC3 PGD2 receptor deficiency. Further we will define the importance of tuft cell infection and inflammasome activation during bacterial gastroenteritis, using a model of infection clearance with an attenuated strain of Salmonella that does not lead to systemic infection. We will also explore the capacity of the tuft cell inflammasome to affect an ongoing type 2 immune response during co-infection with a parasite, Nippostrongylus brasiliensis, and Salmonella. These studies will greatly contribute to our understanding of epithelial cell type specific pathogen sensing and the intestinal immune systems capacity to react to different types of infection. This proposal brings together studies in the Rauch laboratory at Oregon Health and Science University and the expertise of the Tait Wojno laboratory at the University of Washington. Unique expertise in the Tait Wojno laboratory in the use of murine models of helminth infection will be leveraged to collaborate on exciting studies that complement expertise in the Rauch laboratory in epithelial cell biology, inflammasome biology, and intestinal bacterial infection.
项目概要 肠上皮暴露于不同类别的病原体,不仅起到一线作用 防御宿主入侵,而且在以下情况下也向底层固有层中的免疫细胞发出信号 检测到病原体。 NAIP/NLRC4 炎性体已成为重要的先天免疫 细菌性胃肠道感染中肠上皮细胞(IEC)中的传感器,导致快速排出 感染细胞并在病原体识别后释放细胞因子和类二十烷酸。先天免疫的作用 IEC 各个亚型水平上的传感和 NAIP/NLRC4 炎性体尚不清楚。 最近,我们发现 IEC 中簇状细胞独特地释放类二十烷酸前列腺素 D2 (PGD2) 炎症小体激活后。簇细胞是 IEC 的一种罕见亚型,主要因其在抗- 寄生免疫。簇细胞在一般细菌感染过程中的作用以及释放的作用 PGD​​2在肠道免疫中的作用尚不清楚。 我们的初步数据表明,簇细胞炎症小体激活导致组织中 IL-22 水平增加,IL-22 是一种 TH17 细胞或先天性淋巴细胞 (ILC) 产生的抗菌细胞因子,以及簇状细胞 炎症小体的表达可防止小肠细菌定植。根据我们的初步数据 并发表了有关 PGD2 受体表达的数据,我们提出了通过 PGD2 的簇细胞-ILC3 通讯轴。 我们假设簇细胞是小肠感染状态的中枢哨兵,并且能够 改变肠道免疫反应的极化。 我们的目标是利用体内方法确定簇细胞炎症小体激活后导致 IL-22 增加的途径 簇细胞特异性炎性体激活和条件上皮 PGD2 合酶和 ILC3 PGD2 模型 受体缺乏。此外,我们将定义簇细胞感染和炎性小体激活的重要性 在细菌性胃肠炎期间,使用沙门氏菌减毒株清除感染模型 不会导致全身感染。我们还将探讨簇细胞炎性体影响的能力 与巴西尼波圆线虫共同感染期间持续的 2 型免疫反应,以及 沙门氏菌。这些研究将极大地有助于我们了解上皮细胞类型特异性病原体 感知和肠道免疫系统对不同类型感染做出反应的能力。 该提案汇集了俄勒冈健康与科学大学 Rauch 实验室和 华盛顿大学 Tait Wojno 实验室的专业知识。 Tait Wojno 的独特专业知识 使用蠕虫感染小鼠模型的实验室将用于合作开展令人兴奋的研究 补充 Rauch 实验室在上皮细胞生物学、炎性体生物学和 肠道细菌感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Isabella Rauch其他文献

Isabella Rauch的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Isabella Rauch', 18)}}的其他基金

The role of the tuft cell inflammasome in infection
簇细胞炎症小体在感染中的作用
  • 批准号:
    10553185
  • 财政年份:
    2022
  • 资助金额:
    $ 39.4万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了